View on Pubmed.gov 21853082 | View on doi.org 10.1371/journal...
Phosphatase-coupled universal kinase assay and kinetics for first-order-rate coupling reaction.
- R&D Systems Inc., Minneapolis, Minnesota, United States of America. leon.wu@rndsystems.com
Abstract
Kinases use adenosine-5'-triphosphate (ATP) as the donor substrate and generate adenosine-5'-diphosphate (ADP) as a product. An ADP-based phosphatase-coupled kinase assay is described here. In this assay, CD39L2, a nucleotidase, is added into a kinase reaction to hydrolyze ADP to AMP and phosphate. The phosphate is subsequently detected using malachite green phosphate-detection reagents. As ADP hydrolysis by CD39L2 displays a first-order rate constant, relatively simple equations are derived to calculate the coupling rate and the lagging time of the coupling reaction, allowing one to obtain kinase kinetic parameters without the completion of the coupling reaction. ATP inhibition of CD39L2-catalyzed ADP hydrolysis is also determined for correction of the kinetic data. As examples, human glucokinase, P. chrysogenum APS kinase and human ERK1, kinases specific for sugar, nucleotide and protein respectively, are assayed. To assess the compatibility of the method for high-throughput assays, Z' factors >0.5 are also obtained for the three kinases.
References
Anal Biochem. 1990 Nov 1;190(2):188-92
Biochemistry. 1969 Jul;8(7):2782-6
Glycobiology. 2011 Jun;21(6):727-33
Cell. 2000 Oct 13;103(2):211-25
Cited by 26 citations (total)
Journal Article
Comparative Structural and Functional Analysis of Staphylococcus aureus Glucokinase with other Bacterial Glucokinases.
Electronic publication date November 27, 2014
P S Kumar [...] P V G K Sarma et al.
Glucokinase is classified in bacteria based upon having ATP binding site and 'repressor/open reading frames of unknown function/sugar kinases' motif,...
Journal Article Research Support, Non-U.S. Gov't
Expression of the functional recombinant human glycosyltransferase GalNAcT2 in Escherichia coli.
Electronic publication date January 9, 2016
Jennifer Lauber [...] Sabine Gaisser et al.
BACKGROUND
Recombinant protein-based therapeutics have become indispensable for the treatment of many diseases. They are produced using well-established expression systems based...
Conflict of interest statement
MeSH
- •
Substances
- •
- •
- •
- •
- •
- •
- •
- •
- •
- •